AbCellera Biologics Inc Forecast, price target & analysts
AbCellera Biologics Inc Target price 2025 - Analyst rating & recommendation
AbCellera Biologics Inc Classifications & Recommendation:
AbCellera Biologics Inc Price Target
| Target Price | $8.16 |
| Price | $3.61 |
| Potential |
126.04%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target AbCellera Biologics Inc 2026 .
The average AbCellera Biologics Inc target price is $8.16.
This is
126.04%
register free of charge
$17.85
394.46%
register free of charge
$5.05
39.89%
register free of charge
|
|
| A rating was issued by 15 analysts: 13 Analysts recommend AbCellera Biologics Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AbCellera Biologics Inc stock has an average upside potential 2026 of
126.04%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 28.83 | 20.63 |
| 24.19% | 28.45% | |
| EBITDA Margin | -776.69% | -1,159.92% |
| 38.80% | 49.34% | |
| Net Margin | -564.90% | -984.29% |
| 46.74% | 74.24% |
11 Analysts have issued a sales forecast AbCellera Biologics Inc 2025 . The average AbCellera Biologics Inc sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an AbCellera Biologics Inc EBITDA forecast 2025. The average AbCellera Biologics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 AbCellera Biologics Inc Analysts have issued a net profit forecast 2025. The average AbCellera Biologics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.55 | -0.68 |
| 7.84% | 23.64% | |
| P/E | negative | |
| EV/Sales | 22.90 |
11 Analysts have issued a AbCellera Biologics Inc forecast for earnings per share. The average AbCellera Biologics Inc EPS is
This results in the following potential growth metrics and future valuations:
AbCellera Biologics Inc...
Current AbCellera Biologics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | May 16 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Jan 08 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Nov 05 2024 |
| Stifel |
Locked
➜
Locked
|
Locked | Nov 05 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 16 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 16 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Feb 28 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Jan 08 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Nov 05 2024 |
|
Locked
Stifel:
Locked
➜
Locked
|
Nov 05 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
